EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for MBX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2023. Start Trial.
Date Value
June 30, 2026 -0.7777
March 31, 2026 -0.5049
December 31, 2025 -0.4917
September 30, 2025 -0.6321
June 30, 2025 -0.5804
March 31, 2025 -0.7147
December 31, 2024 -0.4664
Date Value
September 30, 2024 -0.5436
June 30, 2024 -0.4751
March 31, 2024 -0.3696
December 31, 2023 -0.265
September 30, 2023 -0.3045
June 30, 2023 -0.228
March 31, 2023 -0.1782

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Amylyx Pharmaceuticals, Inc. -0.3905
ANI Pharmaceuticals, Inc. 1.052
Corcept Therapeutics, Inc. 0.356
Veru, Inc. -0.3032
Johnson & Johnson 2.268

EPS Diluted (Quarterly) Related Metrics